PT2872131T - Oleaceína para tratamento ou prevenção de doenças resultantes de placas ateroscleróticas - Google Patents

Oleaceína para tratamento ou prevenção de doenças resultantes de placas ateroscleróticas

Info

Publication number
PT2872131T
PT2872131T PT13742600T PT13742600T PT2872131T PT 2872131 T PT2872131 T PT 2872131T PT 13742600 T PT13742600 T PT 13742600T PT 13742600 T PT13742600 T PT 13742600T PT 2872131 T PT2872131 T PT 2872131T
Authority
PT
Portugal
Prior art keywords
oleacein
treating
atherosclerotic plaques
preventing diseases
diseases resulting
Prior art date
Application number
PT13742600T
Other languages
English (en)
Inventor
Ewa Czerwinska Monika
Karolina Kiss Anna
Aleksy Naruszewicz Marek
Filipek Agnieszka
Original Assignee
Univ Warszawski Medyczny
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Warszawski Medyczny filed Critical Univ Warszawski Medyczny
Publication of PT2872131T publication Critical patent/PT2872131T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A61K36/638—Ligustrum, e.g. Chinese privet

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT13742600T 2012-07-14 2013-07-13 Oleaceína para tratamento ou prevenção de doenças resultantes de placas ateroscleróticas PT2872131T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL399962A PL227843B1 (pl) 2012-07-14 2012-07-14 Zastosowanie Ligustrum vulgare L. do wytwarzania preparatu zawierającego oleaceinę

Publications (1)

Publication Number Publication Date
PT2872131T true PT2872131T (pt) 2019-02-26

Family

ID=48906224

Family Applications (1)

Application Number Title Priority Date Filing Date
PT13742600T PT2872131T (pt) 2012-07-14 2013-07-13 Oleaceína para tratamento ou prevenção de doenças resultantes de placas ateroscleróticas

Country Status (7)

Country Link
US (1) US9682056B2 (pt)
EP (1) EP2872131B1 (pt)
DK (1) DK2872131T3 (pt)
ES (1) ES2711560T3 (pt)
PL (2) PL227843B1 (pt)
PT (1) PT2872131T (pt)
WO (1) WO2014012871A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2690412B1 (es) 2017-03-10 2019-11-13 Univ Sevilla Procedimiento para la obtención de secoiridoides dialdehídicos
PL423146A1 (pl) * 2017-10-12 2019-04-23 Warszawski Univ Medyczny Oleaceina do zastosowanie w prewencji miażdżycy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009013596A2 (en) 2007-07-23 2009-01-29 Probelte Pharma, S.A. Fortification of nutritional products with olive extracts containing hydroxytyrosol and hydroxytyrosol fortified nutritional products

Also Published As

Publication number Publication date
WO2014012871A1 (en) 2014-01-23
US20160008311A1 (en) 2016-01-14
PL2872131T3 (pl) 2019-05-31
US9682056B2 (en) 2017-06-20
EP2872131B1 (en) 2018-11-21
PL399962A1 (pl) 2014-01-20
ES2711560T3 (es) 2019-05-06
PL227843B1 (pl) 2018-01-31
DK2872131T3 (en) 2019-03-11
EP2872131A1 (en) 2015-05-20

Similar Documents

Publication Publication Date Title
IL258544B (en) Combined treatment for cancer
IL237275A0 (en) Compounds for the treatment of paramoxovirus viral infections
EP2802675A4 (en) PROCESSES FOR TREATING RED SLUDGE
GB201208088D0 (en) Ncam
EP2862620A4 (en) SYSTEM FOR TREATING DISCHARGE GAS
EP2909211A4 (en) PYRAZOLOPYRIMIDINE COMPOUNDS FOR CANCER TREATMENT
HK1212617A1 (zh) 白癜風的治療
HK1210049A1 (en) Combination therapies for treating cancer
EP2807111A4 (en) MULTIFUNCTIONAL NANOMATERIALS FOR THE TREATMENT OF CARCINOMES
HUS2000037I1 (hu) Triazinok Protozoa okozta betegségek kezelésére
GB2521289B (en) Formation treatment system
GB201221123D0 (en) Device for photodynamic treatment
EP2777576A4 (en) TREATMENT SYSTEM
EP2789306A4 (en) TREATMENT SYSTEM
EP2803328A4 (en) TREATMENT SYSTEM
ZA201503005B (en) Ingenol-derived compounds useful for treating cancer
HK1205464A1 (en) Preventing or treating periodontal disease
IL238415B (en) Compounds for the treatment or prevention of diseases or disorders associated with dysregulation of eif4e
EP2934500A4 (en) COMBINATION THERAPY AGAINST CANCER
GB201214877D0 (en) Compounds for treatments of tumors
IL234796B (en) Compounds for the treatment of diseases related to ischemia-reperfusion
PL2855475T3 (pl) Alfa-karboliny do leczenia nowotworu
PL2882432T3 (pl) Sposób leczenia trądziku
PL2872131T3 (pl) Oleaceina do leczenia lub zapobiegania chorobom będących następstwem blaszki miażdżycowej
HK1209040A1 (en) Methods for treating vestibulotoxicity